Dr Fallowfield is a hepatologist at the MRC Centre for Inflammation Research in Edinburgh.

This research focuses on haemodynamic and anti-fibrotic effects of targeted therapies in models of cirrhosis and portal hypertension (high blood pressure in the portal vein).

His proposal sets out to evaluate the efficacy of several potential anti-fibrotic strategies in experimental liver fibrosis/cirrhosis, while determining the relationship between changes in liver histology and portal hypertension.

Add new comment

* indicates a required field

Your email address will not be published on the site and will only be used if we need to contact you about your comment.

View our comments policy